Medical malpractice implications of PSA testing for early detection of prostate cancer.
Prostate cancer screening is controversial. We conducted a national survey of primary care physicians and urologists to examine their use of prostate-specific antigen testing and their views on medical liability issues involved.
Collins
M M
MM
Harvard Medical School, Boston, USA.
Fowler
F J
FJ
Roberts
R G
RG
Oesterling
J E
JE
Annas
G J
GJ
Barry
M J
MJ
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008318:Malpractice / Q000706:statistics & numerical data; D008404:Massachusetts; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000175:diagnosis; D011471:Prostatic Neoplasms / Q000517:prevention & control*
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen